| Entry |
|
|---|
| Name |
Placulumab (USAN/INN) |
|---|
| Formula |
C3404H5262N902O1036S22
|
|---|
| Exact mass |
76056.0652
|
|---|
| Mol weight |
76103.09
|
|---|
| Sequence |
DIQMTQSPSS LSASVGDRVT ITCRASQAID SYLHWYQQKP GKAPKLLIYS ASNLETGVPS
RFSGSGSGTD FTLTISSLLP EDFATYYCQQ VVWRPFTFGQ GTKVEIKRVE PKSSDKTHTC
PPCPAPELLG GPSVFLFPPK PKDTLMISRT PEVTCVVVDV SHEDPEVKFN WYVDGVEVHN
AKTKPREEQY NSTYRVVSVL TVLHQDWLNG KEYKCKVSNK ALPAPIEKTI SKAKGQPREP
QVYTLPPSRD ELTKNQVSLT CLVKGFYPSD IAVEWESNGQ PENNYKTTPP VLDSDGSFFL
YSKLTVDKSR WQQGNVFSCS VMHEALHNHY TQKSLSLSPG K |
|---|
| Type |
Peptide |
|---|
| Class |
Anti-inflammatory
DG01985 Disease modifying anti-rheumatic drug (DMARD)
DG01936 TNF inhibitor
|
|---|
| Efficacy |
Anti-inflammatory, Anti-TNF-alpha antibody |
|---|
| Type |
Monoclonal antibody |
|---|
| Comment |
Treatment of pain and inflammatory diseases
|
|---|
| Target |
|
|---|
| Interaction |
|
|---|
| Brite |
Drug groups [BR:br08330]
Anti-inflammatory
DG01985 Disease modifying anti-rheumatic drug (DMARD)
DG01936 TNF inhibitor
D10320 Placulumab
Target-based classification of drugs [BR:br08310]
Cytokines and receptors
Cytokines
Tumor necrosis factors
TNF (TNFA, TNFSF2)
D10320 Placulumab (USAN/INN)
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
